Research

Life Sciences & Biotechnology

Title :

Genetic validation of actin as a drug target in leishmania and development of drug screening assay system

Area of research :

Life Sciences & Biotechnology

Focus area :

Leishmania drug screening assay

Principal Investigator :

Dr. Amogh Anant Sahasrabuddhe, Scientist, Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh

Timeline Start Year :

2017

Contact info :

Details

Total Budget (INR):

 32,40,000

Organizations involved

Implementing Agency :

Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh

Funding Agency :

Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India

Related Research

Developing a common bean genotype with reduced phytate content by using CRISPR/Cas9 based multi-target gene editing approach
Safe and cost effective method of water reclamation using pellets of extra cellular polymeric substance for removing minor contaminants- endocrine disruptor compounds and repurposing extra cellular polymeric substance for repeated usage
Exosome-like nanovesicle derived phytoferritin, isolated from edible plants as a novel bioavailable source of Iron for the management of anemia
To investigate the relevance of Tumor necrosis factor like weak inducer of apoptosis (TWEAK) as a novel therapeutic target and clinical severity marker in Chronic Obstructive Pulmonary Disorder (COPD) and associated pulmonary hypertension
Elucidating the biosynthetic pathway of triterpene boswellic acid from Boswellia serrata using functional genomics